Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
HIV/AIDS Quality of Care - Reports summarize HIV/AIDS quality of care research from W.E. Cunningham and co-authors
Hormones - Hong Kong Polytechnic University, Department of Applied Biology publishes research in hormones
Immunology - Research findings from Ludwig-Maximilians University update understanding of immunology
Life Sciences - Findings from Ghent University broaden understanding of life sciences
Life Sciences - New life sciences study findings have been reported from M.R. Van Leeuwen et al
Life Sciences - Recent studies from Chosun University, Research Center for Proteineous Materials add new data to life sciences
Life Sciences - Reports from Research Center advance knowledge in life sciences
Life Sciences - Reports on life sciences findings from University Federal of Pernambuco provide new insights
Lung Cancer Therapy - Scientists at University of Istanbul publish new data on lung cancer therapy
Malt Lymphoma Therapy - New malt lymphoma therapy study findings have been reported by researchers at University of Tokyo, Department of Radiology
Prostate Cancer Therapy - Scientists at University of Pennsylvania, Department of Radiation Oncology target prostate cancer therapy
Soft Tissue Infections Epidemiology - Reports from University of Hong Kong, Center of Infection describe recent advances in soft tissue infections epidemiology
Spondylitis Therapy - Research from Ruhr University, Institute of Diagnostic Radiology provides new data on spondylitis therapy
Abbott - Abbott Study Shows Investigational Heat-Stable Norvir Tablet Provides Similar Drug Levels to Current Norvir Capsule
Antibiotics - Destroy Back-to-School Cold and Flu Woes With Duraban's Antibacterial, Antimicrobial Barrier Solution
Antimicrobials - Microban International Enters Into Global Alliance With DyStar Textilfarben GmbH
Argos Therapeutics - Argos Therapeutics' Arcelis Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial
Bionor Immuno - Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program with Start of a Phase IIb Trial in U.S. and Europe
Biotech Business - First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
Bristol-Myers Squibb Company - CASTLE Data Showed Boosted REYATAZ atazanavir sulfate and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender
Cancer - Landmark studies to assess risk of exposure to elevated levels of EMS confirm clear toxicity threshold for DNA damage; Studies emphasize lack of cancer risk for patients exposed to this impurity in Viracept
Drug Development - Cadence Pharmaceuticals Reports Second Quarter 2008 Financial Results and Provides Overview of Clinical Programs
Drug Resistance - Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
Drug Safety - iGuard.org Reaches 500,000-Member Milestone 12 Months Early
Emory University - Study highlights risky behavior, lack of care among HIV-infected crack users
Gilead Sciences, Inc. - Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg in Twelve Countries
GlaxoSmithKline - Analysis of Six Clinical Trials Finds EPZICOM Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
GlaxoSmithKline - Head-to-Head 96-Week Study Shows EPZICOM is Comparable to Truvada in Efficacy and Safety Measures in HIV Treatment-Naive Patients
Helicobacter pylori - New Study Finds Cranberry Works as Well as Probiotics in Reducing Ulcer Causing Bacteria
HIV/AIDS - ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
HIV/AIDS - Landmark Global Survey of People Living with HIV and AIDS Shows Concerning Results that Side Effects are Leading Cause for U.S. Respondents to Discontinue or Switch Treatment Regimens
HIV/AIDS - Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
HIV/AIDS - New Report Finds Investment in AIDS Vaccine and Microbicide R&D Continues to Increase Incrementally in 2007
HIV/AIDS - Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
Merck & Co., Inc. - ISENTRESS raltegravir, Merck's First in Class Integrase Inhibitor, Reduced HIV Viral Load and Increased CD4 Cell Counts Through 96 Weeks in Treatment-Naive HIV-Infected Patients When Taken With Other Anti
Mycobacteria - Pathogen that Causes Disease in Cattle Also Associated with Crohnfs Disease; Research Urgently Needed to Evaluate Potential Risks to Humans
Navilyst Medical - Navilyst Medical Announces Global Debut Today
NovaBay Pharmaceuticals, Inc. - NovaBay Pharmaceutical's NBY CEO, Dr. Ron Najafi, Joins Distinguished Leaders Selected for This Year's PharmaVOICE 100 Most Influential Leaders
Tetraphase Pharmaceuticals Inc. - Tetraphase Pharmaceuticals Completes Series a Financing to Support the Advancement of Breakthrough Synthetic Chemistry Platform
White House Press Office - Remarks by the President and the First Lady at the Signing of H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008